Actively Recruiting

Phase Not Applicable
Age: 3Months - 12Years
All Genders
NCT06456541

Infant Formula in Infants and Children With Cow's Milk Allergy

Led by Abbott Nutrition · Updated on 2026-05-13

61

Participants Needed

9

Research Sites

221 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a multi-center, randomized, double-blinded, placebo-controlled food challenge to be conducted in infants and children with confirmed IgE-mediated cow's milk allergy (CMA), followed by a 7-day open feeding of the experimental formula.

CONDITIONS

Official Title

Infant Formula in Infants and Children With Cow's Milk Allergy

Who Can Participate

Age: 3Months - 12Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant's parent(s) is/are willing for their child to undergo confirmatory testing or must have had at least one of the following within 6 months of enrollment: physician diagnosis of IgE-mediated CMA with clinical history and detectable serum milk-specific IgE >0.7 kU/L or positive skin prick test wheal ≥5 mm; documentation of milk-specific serum IgE >15 kU/L or >5 kU/L if younger than 1 year; documented cow's milk skin prick test wheal >10 mm; or physician-supervised oral food challenge with immediate allergic symptoms.
  • Participant's parent(s) agree for their child to stop oral steroid use within 14 days and antihistamine use within 7 days prior to diagnosis confirmation and food challenges.
  • Participant had followed a strict cow's milk protein-free diet for at least 2 weeks prior to enrollment.
  • Parent(s) confirm intention not to administer any products containing cow's milk protein during the study.
  • Participant is between 3 months and 12 years of age at enrollment.
  • Participant's parent(s) has voluntarily signed and dated an Informed Consent Form approved by an Ethics Committee/Institutional Review Board and provided applicable privacy authorization prior to participation.
Not Eligible

You will not qualify if you...

  • Participant is partially or exclusively breastfed at the time of enrollment.
  • Participant is consuming an amino acid-based formula due to failure on an extensively hydrolyzed formula.
  • Significant chronic medical diseases including major chromosomal or congenital anomalies, gastrointestinal diseases or abnormalities other than CMA, immunodeficiencies, unstable asthma, eczema and/or food allergies treated with biologics, FPIES, eosinophilic esophagitis, and severe uncontrolled eczema.
  • Previous severe anaphylactic reaction to cow's milk within the last two years.
  • Adverse medical history or current condition potentially affecting tolerance or hypoallergenicity testing.
  • Participant has an allergy or intolerance to any ingredient in the study product.
  • Participant is consuming baked milk products.
  • Use of and/or changing dose of high potency steroids.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

Phoenix Children's

Phoenix, Arizona, United States, 85016

Not Yet Recruiting

2

Children's Hospital Colorado

Aurora, Colorado, United States, 80045

Completed

3

Ann & Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, United States, 60611

Actively Recruiting

4

University of Michigan Food Allergy Clinic

Ann Arbor, Michigan, United States, 48106

Actively Recruiting

5

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States, 27599

Actively Recruiting

6

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229

Actively Recruiting

7

Cleveland Clinic

Cleveland, Ohio, United States, 44195

Actively Recruiting

8

Nationwide Children's Hospital

Columbus, Ohio, United States, 43205

Actively Recruiting

9

UT Southwestern Medical Center

Dallas, Texas, United States, 75207

Actively Recruiting

Loading map...

Research Team

K

Kristen DeLuca

CONTACT

J

Jane Schlezinger

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here